Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · IEX Real-Time Price · USD
5.09
+0.03 (0.59%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Anavex Life Sciences Market Cap

Anavex Life Sciences has a market cap or net worth of $417.95 million as of March 28, 2024. Its market cap has decreased by -41.14% in one year.

Market Cap
417.95M
Enterprise Value
274.19M
1-Year Change
-41.14%
Ranking
Category
Stock Price
$5.09

Market Cap Chart

Since January 25, 2007, Anavex Life Sciences's market cap has increased from $59.50M to $417.95M, an increase of 602.44%. That is a compound annual growth rate of 12.02%.

History

DateMarket Cap% Change
Mar 27, 2024415.50M4.55%
Mar 26, 2024397.40M6.37%
Mar 25, 2024373.60M-2.35%
Mar 22, 2024382.60M-8.82%
Mar 21, 2024419.60M-0.19%
Mar 20, 2024420.40M5.79%
Mar 19, 2024397.40M0.40%
Mar 18, 2024395.80M-5.67%
Mar 15, 2024419.60M-0.59%
Mar 14, 2024422.10M-4.46%
Mar 13, 2024441.80M3.47%
Mar 12, 2024427.00M0.19%
Mar 11, 2024426.20M-4.76%
Mar 8, 2024447.50M5.00%
Mar 7, 2024426.20M3.40%
Mar 6, 2024412.20M0.81%
Mar 5, 2024408.90M-2.55%
Mar 4, 2024419.60M-3.23%
Mar 1, 2024433.60M2.72%
Feb 29, 2024422.10M-3.01%
Feb 28, 2024435.20M-0.57%
Feb 27, 2024437.70M7.04%
Feb 26, 2024408.90M1.21%
Feb 23, 2024404.00M-1.80%
Feb 22, 2024411.40M-1.37%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Lexeo Therapeutics 410.34M
Sonida Senior Living 408.54M
Neurogene 406.51M
Mesoblast 398.82M
Terns Pharmaceuticals 398.25M
Zynex 397.30M
Clover Health Investments 391.78M
ESSA Pharma 391.51M
Market Cap Rankings